18+

CELLIVITY / ADULT ACCESS

Are you 18 or older?

CELLIVITY is available to adults only. Supplement pages are general product information; peptide records are not a sales offer and are not for human use.

Age confirmation is a declaration, not identity verification. Restricted research access still requires separate professional eligibility checks.Privacy and legal notice ↗
Skip to content
CELLIVITY
Supplements
Peptides⌄
Research areasAll Peptides→Metabolic→Recovery→Nootropic→Energy→Aesthetics→Neuron→
Peptide calculatorAbout CELLIVITY
Featured productsRetatrutide฿3,700BPC-157฿1,300MOTS-c฿1,500GHK-Cu฿1,400
CalculatorScienceAbout Us
🇬🇧EN⌄
🇬🇧EnglishEN🇭🇺MagyarHU🇹🇭ไทยTH🇷🇺РусскийRU
Browse products ↗○LoginCart0
Supplements
Peptides+
All PeptidesMetabolicRecoveryNootropicEnergyAestheticsNeuronPeptide calculatorRetatrutide฿3,700BPC-157฿1,300MOTS-c฿1,500GHK-Cu฿1,400
Calculator↗ScienceAbout UsLogin / Create accountBrowse products
Currency
Thailand retail pricesProduct laboratory references18+ access
Peptides/Ipamorelin
Ipamorelin — CELLIVITYOpen full-size image ↗
Packaging concept; the selected format is shown below.Selected format: 10 mg
CELLIVITY PEPTIDE LABS · CEL-P-IPA-001

Ipamorelin

Lyophilised research-vial concept

For laboratory research only · Not intended for human or veterinary use.

Select format
THAILAND LAUNCH PRICE฿1,80010 mg · per vial · tax and delivery confirmed at enquiry
Sourced on enquiry · lead time confirmed individuallyAvailability is confirmed for this exact format before any commitment.
1
Selected10 mg · 1 vial · ฿1,800
Check availability ↗
Product reference filesQuality reviewThailand support
Product record
CEL-P-IPA-001
Reference files
1 · CELLIVITY lot review pending
Product details ↓Lab documents (1) ↓Delivery ↓Check availability ↓
Lab documents

PRODUCT DESCRIPTION

Ipamorelin,
made legible.

Ipamorelin is a synthetic pentapeptide investigated as a ghrelin-receptor agonist and growth-hormone secretagogue. Its receptor activity makes it an endocrine research topic, not a general wellness ingredient.

Research focus

Ghrelin-receptor selectivity and growth-hormone signalling research.

Current evidence context

Human evidence is limited and does not establish a consumer recovery or longevity use. Peptide impurities and aggregation can also change immunogenicity and make product quality part of the scientific question.

Questions this record follows

  • How selective is the receptor signal under controlled assay conditions?
  • How do exposure and aggregation affect endocrine responses?
  • What human safety and long-term metabolic data remain unresolved?
Evidence boundaryEndocrine, metabolic, immunogenicity and long-term risks remain uncertain.

Follow the sources

Registry entries identify reference substances. Literature links describe research and do not certify this product or its batch.

  • Compound registryPubChem · CID 9831659 ↗
  • Literature searchipamorelin human trial — PubMed research index ↗

04 — LAB RESULTS & DOCUMENTS

One product. One place. One evidence trail.

Exact CELLIVITY-batch review is pending. Reference files below describe their own declared samples.

Purity, identity, per-vial content and sterility are separate results.

Product
Ipamorelin
Record
CEL-P-IPA-001
Files received
1
Ipamorelin supplier certificate — original uploaded document
DOCUMENT RECEIVED · REVIEW PENDING

Ipamorelin supplier certificate

Supplier document declares 99.1% purity with RP-HPLC and ESI-MS methods.

Source
PepNexa supplier submission
Document type
Supplier certificate
Sample
Ipamorelin
Declared lot
PEPNEXA-2026-IPA-0447
Report date
29 Jun 2026
Review state
Received — CELLIVITY review pending
Open original image ↗

AVAILABILITY

Tell us what
your lab needs.

Request current availability for a lawful institutional, analytical or laboratory purpose. We confirm the exact presentation, price, batch and document state before any next step.

  • Exact presentation review
  • Jurisdiction and purpose check
  • Batch-document confirmation
  • No medical or human-use guidance
SELECTED PRODUCTIpamorelinCEL-P-IPA-001 · response after manual review

Ipamorelin · 10 mg × 1

Ipamorelin: before you enquire

What exactly does the selected format mean?+

The mg or IU value is the declared material content per vial; it is not the container volume. Your selected presentation and quantity are saved with your enquiry. The final price is confirmed in the response.

Which batch will be supplied?+

The specific batch and its documents are confirmed in the response. Files shown here may be supplier reference samples; the current record does not yet contain a qualified CELLIVITY lot dossier.

When can it arrive in Thailand?+

For confirmed local stock, the planned window is 2–3 working days in Thailand. Pattaya timing is agreed directly. Incoming or specially sourced products have a separate estimate, confirmed before a commitment.

Can I enquire about several products together?+

Yes. Add each format and quantity to the cart, then send one availability enquiry. Your selected items are kept together for review.

CELLIVITY

Ipamorelin

CEL-P-IPA-001 · 10 mg

Ipamorelin is a synthetic pentapeptide investigated as a ghrelin-receptor agonist and growth-hormone secretagogue. Its receptor activity makes it an endocrine research topic, not a general wellness ingredient.

Ghrelin-receptor selectivity and growth-hormone signalling research.

Other names
NNC-26-0161 · Aib-His-D-2-Nal-D-Phe-Lys-NH2
PubChem CID
9831659
CAS number
170851-70-4
Molecular formula
C38H49N9O5
Molecular weight
711.9 g/mol
Peptide length
5 amino acids
Compound class
Synthetic pentapeptide ghrelin-receptor agonist

Follow the sources

Human evidence is limited and does not establish a consumer recovery or longevity use. Peptide impurities and aggregation can also change immunogenicity and make product quality part of the scientific question.

  • How selective is the receptor signal under controlled assay conditions?
  • How do exposure and aggregation affect endocrine responses?
  • What human safety and long-term metabolic data remain unresolved?

Lab documents

CELLIVITY lot review pending

  • Ipamorelin supplier certificate · 29 Jun 2026 · PEPNEXA-2026-IPA-0447

Endocrine, metabolic, immunogenicity and long-term risks remain uncertain.

CELLIVITY · cellivity@gmail.com

← Back to collection
CELLIVITY

Your future is cellular.

SupplementsSupplementsPeptidesAbout Us
Product statusLaunch updatesLab document libraryPeptide dossier index
CELLIVITYAbout UsLanguagesSafetyContact
LegalMedical disclaimerPrivacyPrivacy request / unsubscribeTerms
Laboratory catalogue

18+ access. Peptide records support lawful laboratory enquiries only. Exact availability and lot documents are confirmed separately; no human or veterinary use instructions are provided.

Delivery, storage and responsibility

Delivery method, fees and the committed timeframe are set out in the accepted quotation. Delays or damage are handled with the recipient; CELLIVITY remains responsible for its agreed packaging and fulfilment. After receipt, the recipient must follow the documented storage conditions for the specific batch and report deviations. Research materials are intended for lawful work in an appropriate professional setting, not human or veterinary self-use. These terms do not exclude statutory liability or mandatory customer rights.

Full research-use terms →
© 2026 CELLIVITY. Pre-launch.Riviera Jomtien, 29/111, Pattaya 20150, ThailandControlled contact route

CELLIVITY / STAY IN THE LOOP

Follow the next
chapter.

New product records, laboratory documents and release news. Choose to hear from us when there is something useful to share.

  • New laboratory documents
  • Product availability updates
  • News from CELLIVITY
18+ only. Optional email updates. You can unsubscribe at any time.
Ipamorelin research dossier — CELLIVITY